Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

12.18
BATS BZX Real-Time Price
As of 3:07pm ET
 +0.135 / +1.12%
Today’s Change
7.18
Today|||52-Week Range
14.38
+23.23%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close12.04
Today’s open11.86
Day’s range11.83 - 12.23
Volume104,366
Average volume (3 months)1,888,169
Market cap$1.6B
Dividend yield--
Data as of 3:07pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-246.41%
Earnings growth (next 5 years)+55.33%
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book35.88

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc+0.32+0.58%
FPRXFive Prime Therapeut...+0.54+1.16%
ONCESpark Therapeutics I...-1.06-1.75%
RDUSRadius Health Inc-1.87-4.33%
Data as of 3:07pm ET, 02/24/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs